Envista Holdings Operating Income 2018-2025 | NVST

Envista Holdings operating income from 2018 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Envista Holdings Annual Operating Income
(Millions of US $)
2024 $-1,038
2023 $32
2022 $319
2021 $306
2020 $44
2019 $236
2018 $298
2017 $387
Envista Holdings Quarterly Operating Income
(Millions of US $)
2025-09-30 $58
2025-06-30 $46
2025-03-31 $39
2024-12-31 $46
2024-09-30 $21
2024-06-30 $-1,153
2024-03-31 $48
2023-12-31 $-203
2023-09-30 $83
2023-06-30 $79
2023-03-31 $72
2022-12-31 $88
2022-09-30 $75
2022-06-30 $65
2022-03-31 $92
2021-12-31 $46
2021-09-30 $82
2021-06-30 $83
2021-03-31 $95
2020-12-31 $115
2020-09-30 $62
2020-06-30 $-108
2020-03-31 $-25
2019-12-31 $36
2019-09-30 $79
2019-06-30 $76
2019-03-31 $45
2018-12-31
2018-09-30 $81
2017-12-31
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $3.297B $2.511B
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $218.907B 25.23
EssilorLuxottica (ESLOY) FR $167.835B 0.00
Boston Scientific (BSX) US $149.593B 34.21
Stryker (SYK) US $135.768B 26.96
Medtronic (MDT) IE $118.854B 16.76
Lonza Group Ag (LZAGY) CH $46.878B 0.00
Agilent Technologies (A) US $41.493B 26.85
ResMed (RMD) US $36.500B 25.26
GE HealthCare Technologies (GEHC) US $33.472B 16.01
Koninklijke Philips (PHG) NL $27.202B 17.77
Terumo (TRUMY) JP $24.340B 28.84
Insulet (PODD) US $22.536B 69.94
Zimmer Biomet Holdings (ZBH) US $17.585B 10.97
Smith & Nephew SNATS (SNN) GB $14.234B 0.00
Sunny Optical Technology (SNPTF) CN $11.495B 0.00
Demant (WILYY) DK $7.359B 0.00
ICU Medical (ICUI) US $3.437B 21.82
Lantheus Holdings (LNTH) US $3.361B 10.24
Haemonetics (HAE) US $3.299B 14.68
Shandong Weigao Medical Polymer (SHWGF) CN $3.120B 0.00
Prestige Consumer Healthcare (PBH) US $2.907B 13.26
LeMaitre Vascular (LMAT) US $1.992B 40.09
Curaleaf Holdings (CURLF) CA $1.977B 0.00
Perrigo (PRGO) IE $1.961B 4.91
Phibro Animal Health (PAHC) US $1.858B 18.56
Green Thumb Industries (GTBIF) US $1.612B 70.64
Tilray Brands (TLRY) CA $1.471B 0.00
Neogen (NEOG) US $1.382B 26.50
Kestra Medical Technologies (KMTS) US $1.359B 0.00
QuidelOrtho (QDEL) US $1.340B 8.62
AdaptHealth (AHCO) US $1.272B 18.43
BioLife Solutions (BLFS) US $1.266B 375.57
InMode (INMD) IL $0.923B 10.43
Maravai LifeSciences Holdings (MRVI) US $0.792B 0.00
Valneva SE (VALN) FR $0.764B 0.00
VAREX IMAGING (VREX) US $0.500B 17.23
SNDL (SNDL) CA $0.491B 0.00
Verano Holdings (VRNO) US $0.474B 0.00
Evolus (EOLS) US $0.457B 0.00
Omeros (OMER) US $0.449B 0.00
Cresco Labs (CRLBF) US $0.438B 0.00
CeriBell (CBLL) US $0.437B 0.00
Surmodics (SRDX) US $0.391B 0.00
Cerus (CERS) US $0.307B 0.00
Brainsway (BWAY) IL $0.306B 62.00
Canopy Growth (CGC) CA $0.305B 0.00
Sanuwave Health (SNWV) US $0.294B 0.00
SEMPERIT AG HLD (SEIGY) AT $0.286B 0.00
Aurora Cannabis (ACB) CA $0.263B 155.67
High Tide (HITI) CA $0.262B 0.00
Capricor Therapeutics (CAPR) US $0.254B 0.00
Sanara MedTech (SMTI) US $0.251B 0.00
TerrAscend (TSNDF) CA $0.249B 0.00
Viemed Healthcare (VMD) US $0.243B 19.36
Quanterix (QTRX) US $0.238B 0.00
Owens & Minor (OMI) US $0.228B 2.29
Organigram Global (OGI) CA $0.222B 0.00
Exagen (XGN) US $0.214B 0.00
Vireo Growth (VREOF) US $0.210B 0.00
TriSalus Life Sciences (TLSI) US $0.199B 0.00
Utah Medical Products (UTMD) US $0.184B 16.18
FitLife Brands (FTLF) US $0.174B 21.46
OraSure Technologies (OSUR) US $0.167B 0.00
Jushi Holdings (JUSHF) US $0.140B 0.00
Biote (BTMD) US $0.122B 4.92
Sharps Technology (STSS) US $0.114B 0.00
Quipt Home Medical (QIPT) US $0.106B 0.00
Oramed Pharmaceuticals (ORMP) US $0.093B 0.00
Fonar (FONR) US $0.093B 13.49
MacroGenics (MGNX) US $0.090B 0.00
ImmuCell (ICCC) US $0.055B 32.00
Nephros (NEPH) US $0.046B 33.00
Cytosorbents (CTSO) US $0.045B 0.00
Jin Medical (ZJYL) CN $0.041B 0.00
Veru (VERU) US $0.038B 0.00
Rockwell Medical (RMTI) US $0.037B 0.00
Zynex (ZYXI) US $0.036B 0.00
Bonk (BNKK) US $0.034B 0.00
United-Guardian (UG) US $0.029B 14.65
Modular Medical (MODD) US $0.028B 0.00
Allurion Technologies (ALUR) US $0.014B 0.00
Cellectar Biosciences (CLRB) US $0.011B 0.00
INLIF (INLF) CN $0.011B 0.00
IM Cannabis (IMCC) CA $0.007B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Flora Growth (FLGC) US $0.006B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.005B 0.00
Akanda (AKAN) CA $0.001B 0.00
Trinity Biotech (TRIB) IE $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00
InterCure (INCR) IL $0.000B 0.00